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   In order to investigate an in vivo production of some serum proteins which are most commonly
elevated in renal cancer patients and tumor markers in renal cancer tissue， their goncentrations in
renal arterial and venous blood samples have been determined in 11 patients with renal cancer． ln
other 2 groups， one consisting of 13 renal cancer patients without metastasis and another 13 renal
cancer patients with metastasis， pre一 and post－operative chap． ges of concentration of 36 serum
proteins in peripheral blood have been studied as well．
   The 36 serum protejns were quantitatively deterrnined by a rnicro－single radial immunodiffusion
method described by Migita and 5 t．umor markers， beta－human chorionic gonadotropin （P－HCG），
alpha－fetoprotein （AFP）， ferritin， carcinoembryonic antigen （CEA） and beta－2 microglobulin （BMG），
were determined using commercially available radioirnmuno4ssay kits．
   From the data obtained from the 11 patients， it was not possible to assure the production of any
serum protein in renal cancerous tissue． A large variety of serum proteins showing a decrease of
the concentration in renal venous blood had a relatively close relationship to patients with a large
tumor lesion． Although a sporadic increase ofseveral serum proteins in the venous blood was observed，
it was not limited to a specified patient，
   Productions of P－HCG， BMG and ferritin in renal cancerous tissue were strongly suggested in
1， 1 and 5 patients， respectively．
   In a group of the 13 patients without metastasis， abnormal levels of Alb， aiAT， criAG， Hp， Cg
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and Hx returned to a normal range after nephrectomy， and these post－operative criAT， aiAG， Hp
and Hx levels showed a significant difference as compared with post－operative levels of those proteins
in the 13 patients with皿etastasis． These results suggested that post－Gperative changes of the 4 serum
proteins would be a usefu1 parameter for the occurrence of a deteriorating event in the subsequent
course， e．g．， tumor recurrence or metastasis development．

















tin， renin， prostaglandin， carcinoernbryonic antigen























Table 1．Summary of 11 patients who underwent collection of renal
arterial and venous blood samples








































































































































































































































aiX， Hp， Cp， Clsl， Cg， Cs， Hx， P2111， P－Lp， C4，
C，PAなど13種の血清蛋白につき観察したが，腎静脈
Table 3．Alteration between renal arterial and venous blood with respect to
36 serum proteins
Smajl tumor greup ｛5potients）
     No difference between renal arteriol ond venous blood
     Decrease in renal venous blood
     工n（：reose ｝n renal venovs blood
Large tumor group ｛6patients）
     No ditterence between renal arterial and venous blood
     Decrea＄e ln renal venous blood
     工ncrease in renol venous blood
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Table 5． Alteration between renal arterial and
     venous blood with respect to aiAT，
     criAG， a iX， Hp， Cp， Clsl， Cg， Cs，
     Hx， P2111， PLp， C4 and C3PA
Table 6．Alteration between renal arterial and
 venous blood with respect to aiAT，




in rena［ venous blood
 Sma l l tumor group
 Large tumor group
in renal venous blood
 Small tumor group
 Large tumor group
5 ／ 6 ［ （ 4，9 01． ）
5／77 ［ 65 el．）
6／6i（ 9．8 01．｝
14／ 77 （ 18．2 e／． ）
rncrease in renal venous blood
      Small tumor group
      Large iumor grovp
Decrease in renai venous blood
      SmoH tumor group
      Large tumor group
























Table 7． Serum concentrations of tumor markers






























































































































A ： Renal arterial blood
V ： Renal venous blood
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癌での合成が強く推定された．



































 無転移症例では腎摘除術後Alb，α1， AT，α1AG， Hp，
Cg， Hxなどが有意の変動をもって正常値に移行した．
Table 8． Postoperative changes of clinically remarkable proteins
Ser．u［n NorFr．ialproteins    adults
 Patients with renal cancer
Preoperation Pestoperation
Aib IOO士15％








































































M一：without metastasis  ＊ pくO．05





















































































































































 2．β一HCG， AFP， CEA， ferritin， BMGの腎癌で
の合成を検討し，β一HCG 1例， BMG 1例， ferritin
5例において，それぞれ産生の可能性が示唆された．
 3．無転移腎癌13症例の腎摘除術後に，Alb，αiAT，
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